During the past decade, Diakonie-Klinikum Stuttgart conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Diakonie-Klinikum Stuttgart" #1 sponsor was "University of Ulm" with 10 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 5 trials sponsored, "German CLL Study Group" with 4 trials sponsored, "Aesculap AG" with 2 trials sponsored and "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Diakonie-Klinikum Stuttgart" #1 collaborator was "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator, "EBMT Solid Tumors Working Party" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "German CLL Study Group" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Diakonie-Klinikum Stuttgart" are "Acute Myeloid Leukemia" (7 trials), "Lymphoma" (6 trials), "Leukemia" (5 trials), "Acute Myeloid Leukemia (AML)" (4 trials) and "Chronic Lymphocytic Leukemia" (4 trials). Many other conditions were trialed in "Diakonie-Klinikum Stuttgart" in a lesser frequency.

Most popular intervention types in "Diakonie-Klinikum Stuttgart" are "Drug" (28 trials), "Biological" (11 trials), "Other" (6 trials), "Radiation" (6 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (8 trials), "Cytarabine" (6 trials), "filgrastim" (6 trials), "radiation therapy" (6 trials) and "vincristine sulfate" (6 trials). Other intervention names were less common.

The vast majority of trials in "Diakonie-Klinikum Stuttgart" are 34 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Diakonie-Klinikum Stuttgart". undefined are not yet recruiting, 9 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Diakonie-Klinikum Stuttgart, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Diakonie-Klinikum Stuttgart, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".